Search results
Results from the WOW.Com Content Network
They can be designed to specifically target cancer biomarkers, allowing for highly sensitive and accurate detection of cancer cells or molecules associated with cancer. Gene therapy: Nanocarriers, such as lipid nanoparticles or polymer nanoparticles, can deliver therapeutic genes to cancer cells. This approach aims to modify the genetic makeup ...
In polymer chemistry, in situ polymerization is a preparation method that occurs "in the polymerization mixture" and is used to develop polymer nanocomposites from nanoparticles. There are numerous unstable oligomers ( molecules ) which must be synthesized in situ (i.e. in the reaction mixture but cannot be isolated on their own) for use in ...
Polymer-drug conjugates are drug molecules held in polymer molecules, which act as the delivery system for the drug. Polymer drugs have passed multidrug resistance (MDR) testing and hence may become a viable treatment for endocrine-related cancers. A cocktail of pendant drugs could be delivered by water-soluble polymer platforms.
Nanoparticles of natural polymers such as chitosan are commonly used adjuvants in modern vaccine formulations. [63] Ceria nanoparticles appear very promising for both enhancing vaccine responses and mitigating inflammation, as their adjuvanticity can be adjusted by modifying parameters such as size, crystallinity, surface state, and stoichiometry.
It can be directed to the location of cancer cells with sustained release behavior. Studies have also been done on gold nanoparticle responses to local near-infrared (NIR) light as a stimuli for drug release. In one study, gold nanoparticles functionalized with double-stranded DNA encapsulated with drug molecules, were irradiated with NIR light.
The most commonly used nanoparticles for intracellular delivery of nucleic acids are based on assemblies of cationic lipids and polymers. These cationic molecules condense DNA plasmids (~50-200 nm), mRNA (10-100 nm) and other nucleic acids (see "Properties of common molecules of interest for intracellular delivery") into compact nanoparticles ...
A Pilot Study of AuroLase™ Therapy (gold nano shells) in refractory and/or recurrent tumors of the head and neck was completed in 2009 [a] and two trials are currently using AuroLase™ therapy for the treatment of primary/metastatic lung cancer [b] and for prostate cancer. [c] Other gold nanoparticles on the market are mostly for synthesis ...
Selective organ targeting (SORT) is a novel approach in the field of targeted drug delivery that systematically engineers multiple classes of lipid nanoparticles (LNPs) to enable targeted delivery of therapeutics to specific organs in the body.